Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Edan

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 11, 1998
Identification of a Val 145 Ile substitution in the human myelin oligodendrocyte glycoprotein: lack of association with multiple sclerosis. The Réseau de Recherche Clinique INSERM sur la Susceptibilité Génétique à la Sclérose en PlaquesD Rodriguez, B Della Gaspera, B Zalc, et al.
Annales De Medecine Interne|January 1, 1981
[Hemochromatosis]M Simon, J P Hespel, P Brissot, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1981
[Diagnosis of idiopathic hemochromatosis in 1981]M Simon, J P Hespel, P Brissot, et al.
Human Immunology|March 1, 1995
TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosisH Moins-Teisserenc, G Semana, M Alizadeh, et al.
Revue Neurologique|February 19, 2022
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patientsM Lefort, G Le Corre, E Le Page, et al.
La Nouvelle Presse Medicale|February 3, 1979
[Demonstration by iron overloading study and HLA genotyping of recessive transmission of idiopathic haemochromatosis in two pseudodominant pedigrees (author's transl)]M Simon, J P Hespel, R Fauchet, et al.
Journal of Neuroimmunology|February 2, 2010
MGAT5 alters the severity of multiple sclerosisB Brynedal, J Wojcik, F Esposito, et al.
Neurology|September 26, 2002
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MSR G Ghalie, G Edan, M Laurent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the studyG Comi, F Barkhof, L Durelli, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 11, 1998
Identification of a Val 145 Ile substitution in the human myelin oligodendrocyte glycoprotein: lack of association with multiple sclerosis. The Réseau de Recherche Clinique INSERM sur la Susceptibilité Génétique à la Sclérose en PlaquesD Rodriguez, B Della Gaspera, B Zalc, et al.
Annales De Medecine Interne|January 1, 1981
[Hemochromatosis]M Simon, J P Hespel, P Brissot, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1981
[Diagnosis of idiopathic hemochromatosis in 1981]M Simon, J P Hespel, P Brissot, et al.
Human Immunology|March 1, 1995
TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosisH Moins-Teisserenc, G Semana, M Alizadeh, et al.
Revue Neurologique|February 19, 2022
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patientsM Lefort, G Le Corre, E Le Page, et al.
La Nouvelle Presse Medicale|February 3, 1979
[Demonstration by iron overloading study and HLA genotyping of recessive transmission of idiopathic haemochromatosis in two pseudodominant pedigrees (author's transl)]M Simon, J P Hespel, R Fauchet, et al.
Journal of Neuroimmunology|February 2, 2010
MGAT5 alters the severity of multiple sclerosisB Brynedal, J Wojcik, F Esposito, et al.
Neurology|September 26, 2002
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MSR G Ghalie, G Edan, M Laurent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the studyG Comi, F Barkhof, L Durelli, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Pageof 13